Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PurePell is a specialized pharmaceutical brand and business unit focused on the manufacturing and distribution of bioidentical hormone replacement therapy (BHRT) pellets. Operating as a brand under AnazaoHealth, a Belmar Pharma Solutions company, PurePell utilizes a proprietary pelletization process to ensure consistent drug release and high-quality standards for clinicians and patients. The company's product line primarily includes testosterone and estradiol pellets designed for subcutaneous implantation to treat hormonal imbalances. PurePell serves as a key provider in the 503B outsourcing space, adhering to stringent FDA Current Good Manufacturing Practice (cGMP) regulations to provide sterile, long-acting hormonal treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Purepell.